| |
| |
|
| Insider
Information: |
Lewis-Hall Freda C |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
719,652 |
|
|
Indirect Shares
|
4,598,167 |
|
|
| Direct
Value |
$36,863,488 |
|
|
|
Indirect Value
|
$120,182 |
|
|
| Total
Shares |
5,317,819 |
|
|
| Total
Value |
$36,983,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Medicines Develop... |
2009-03-19 |
53,334 |
2008-06-18 |
0 |
Premium* |
|
|
Pfizer Inc |
PFE |
Executive Vice President |
2019-02-27 |
375,244 |
2019-02-27 |
4,320 |
Premium* |
|
|
Tenet Healthcare Corp |
THC |
Director |
2016-05-13 |
15,314 |
2014-12-24 |
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director |
2024-05-16 |
14,667 |
2019-09-17 |
4,593,847 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
19,688 |
2020-04-22 |
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
|
2024-03-26 |
241,405 |
2022-03-31 |
0 |
Premium* |
|
|
1life Healthcare Inc |
ONEM |
|
2023-02-22 |
0 |
2022-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-24 |
4 |
OE |
$18.90 |
$1,736,456 |
D/D |
91,876 |
313,499 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
D |
$41.91 |
$2,257,783 |
D/D |
(53,221) |
334,803 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$3,794,983 |
D/D |
(89,126) |
375,244 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2018-02-28 |
4 |
OE |
$27.37 |
$2,863,614 |
D/D |
104,626 |
384,219 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-23 |
4 |
OE |
$21.03 |
$1,839,052 |
D/D |
87,449 |
388,024 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$2,625,939 |
D/D |
81,475 |
416,278 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
48,092 |
464,370 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2019-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
4,543,847 |
4,543,847 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
Director |
– • • |
2019-09-17 |
4 |
B |
$18.00 |
$900,000 |
I/I |
50,000 |
4,593,847 |
2.25 |
- |
|
59 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
